Quanta Therapeutics
PrivateLast Round
Series D
May 22, 2023
Total Funding Raised
$142.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Quanta Therapeutics operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Series D round in May 2023.
Quanta Therapeutics is a biotechnology company that develops oral small molecule therapeutics for RAS-driven cancers using a proprietary Second Harmonic Generation optical platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Quanta Therapeutics Comparables
Compare Quanta Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kestrel Therapeutics | 88% | |
| Kumquat Biosciences | 86% | |
| Tyligand Bioscience | 85% |
For institutional investors. Book with your work email.
Quanta Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 22, 2023 | ||||
| Series D | May 10, 2023 | ||||
| Series C | Oct 26, 2021 | ||||
| Series A | Sep 5, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Quanta Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series D, Series C |
| Surveyor Capital | Series D, Series C |
| Avidity Partners Management | Series D |
| Vida Ventures | Series D, Series C, Series B |
| Avidity Partners | Series D |
| WS Investment Company | Series D |
| Logos Capital | Series C, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 72% MoM.
- Oct 24, 2025
Presenting first clinical data for drug candidate QTX3034 at AACR-NCI-EORTC conference.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 19, 2026
Quanta Therapeutics, Inc. plans to present clinical data for QTX3034 in combination with cetuximab, with or without FOLFOX chemotherapy, in patients with colorectal cancer at the European Society for Medical Oncology (ESMO) Annual Congress in Spain in Oct '26.
For institutional investors. Book with your work email.
Quanta Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Quanta Therapeutics's valuation, stock price, and market status.
Is Quanta Therapeutics a public or private company?
Quanta Therapeutics is a private company.
What is the current stock price of Quanta Therapeutics?
Quanta Therapeutics is a private company, so its shares have no public market price. Caplight tracks Quanta Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Quanta Therapeutics worth (valuation)?
Valuation information for Quanta Therapeutics is not publicly available.
Can I buy Quanta Therapeutics stock?
Quanta Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Quanta Therapeutics's last funding round?
Quanta Therapeutics's most recent funding round was Series D on May 22, 2023.
Who are the main investors in Quanta Therapeutics?
Key investors in Quanta Therapeutics include Surveyor Capital, Avidity Partners Management, Vida Ventures, Avidity Partners, Citadel.
Will Quanta Therapeutics IPO soon?
No public IPO plans have been announced for Quanta Therapeutics.
How can I track Quanta Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Quanta Therapeutics's shares on secondary markets.